Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid in Ovarian Cancer Surgery
NCT06879353Completed
- Sponsor
- Sheikh Zayed Medical College
- Start
- Jul 2023
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial in Bleeding comparing Group Tranexamic Acid with Group Placebo (2 arms). Primary endpoint: Requirement of Blood Transfusion After Surgery. Started Jul 2023; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Bleeding
Beyond the preview
Go deeper on NCT06879353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06879353.